Delivery Order SPE2DB22D2007-SPE2DB23FJ5VV
Award Date 9/7/23
Potential Completion Date 9/28/23
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,857.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561918282 TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products. Amerisourcebergen Drug Corporation will deliver the products to a location in Conshohocken, Pennsylvania by September 14, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set...
- The Defense Logistics Agency awarded a delivery order valued at $17,009.24 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials. This firm fixed-price, competitively awarded contract was issued on August 12, 2025, with an ultimate completion date of September 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside acquisition, this delivery order was open to competition among qualified...
- Defense Logistics Agency awarded a $8,730.60 firm fixed price delivery order to Amerisourcebergen Drug Corp for TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products. As the parent company, Amerisourcebergen Corporation will provide the products, with performance taking place in Conshohocken, Pennsylvania by November 8, 2023. No set-aside designation was used for this award made under an existing vehicle to supply pharmaceuticals in support of DLA and Department of Defense health programs.
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,504.62 on September 19, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of October 10, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside award made through open competition, reflecting AmerisourceBergen's demonstrated capability to fulfill...
- The Defense Logistics Agency Troop Support Medical awarded a $23,573 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4561724223 TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products to be delivered to a location in Conshohocken, Pennsylvania by August 28, 2023 in support of DLA medical programs. Amerisourcebergen will serve as the prime contractor to supply the requested oncology drug to the agency by the scheduled end date, with no...
- The Defense Logistics Agency awarded a $8,504.62 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tecentriq (atezolizumab) 840 mg/14 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 14, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $25,189 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tecentriq Hybridza 1,875 mg 15 ml pharmaceutical product. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $34,018.40 on September 22, 2025, for the supply of Tecentriq 840 mg/14 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tecentriq is a specialized oncology pharmaceutical product, reflecting the company's role as a...
- The Defense Logistics Agency awarded a $17,009.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on May 19, 2025, with completion targeted for June 10, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999,999,999 ceiling and runs through December 2026. The pharmaceutical distributor is...
- Amerisourcebergen Drug Corp has received a $7,857.74 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 29, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide...